Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2016

01-08-2016 | Original Article

Leukocytes apoptosis and adipocytokines in children with beta thalassemia major

Authors: Khalid I. Elsayh, Wafaa S. Mohammed, Asmaa M. Zahran, Khaled Saad

Published in: Clinical and Experimental Medicine | Issue 3/2016

Login to get access

Abstract

β-Thalassemia is a significant public health problem in Egypt. Infectious complications represent the second most common cause of mortality and the major cause of morbidity in β-thalassemia major (BTM). The increased susceptibility of these patients to infectious diseases has been attributed to the abnormalities of the immune system, which is evident by systemic inflammation and immune deficiency. In a case control study, 35 patients with BTM were compared with 30 sex- and age-matched children who served as controls. Serum ferritin, high-sensitive CRP (hsCRP), leptin and adiponectin levels were determined in all subjects. Apoptosis of neutrophils and lymphocytes was measured by the Annexin V-fluoroisothiocyanate binding assay. Serum leptin was significantly lower in patients when compared to controls. In contrast, adiponectin and hsCRP levels were significantly higher in the patients than the controls. Positive correlation was found between adiponectin and hsCRP. BTM patients had significantly higher total leukocytes, neutrophils and lymphocytes compared with controls. BTM children exhibited a significantly increased apoptosis in T-lymphocytes; however, there was no significant difference in the percentage of apoptosis of B-lymphocytes and neutrophils between the patients and the controls. There was a significant negative correlation between serum leptin and the percentage of apoptotic T-lymphocytes. Our BTM patients had a high percentage of apoptotic T-lymphocyte in comparison with controls. In addition, they had disturbed serum levels of adipocytokines and inflammatory markers. These derangements could have a role in the immunological disturbance observed in thalassemic patients.
Literature
1.
go back to reference Fahim FM, Saad K, Askar EA, et al. Growth parameters and vitamin D status in children with thalassemia major in upper Egypt. Int J Hematol Oncol Stem Cell Res. 2013;7(4):10–4.PubMedPubMedCentral Fahim FM, Saad K, Askar EA, et al. Growth parameters and vitamin D status in children with thalassemia major in upper Egypt. Int J Hematol Oncol Stem Cell Res. 2013;7(4):10–4.PubMedPubMedCentral
2.
go back to reference Shawky RM, Kamal TM. Thalassemia intermedia: an overview. Egypt J Med Hum Genet. 2012;13:245–55.CrossRef Shawky RM, Kamal TM. Thalassemia intermedia: an overview. Egypt J Med Hum Genet. 2012;13:245–55.CrossRef
3.
go back to reference Farmakis D, Giakoumis A, Polymeropoulos E, et al. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit. 2003;9(1):RA19–22.PubMed Farmakis D, Giakoumis A, Polymeropoulos E, et al. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit. 2003;9(1):RA19–22.PubMed
4.
go back to reference Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–93.PubMed Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–93.PubMed
5.
go back to reference Ricerca BM, Di Girolamo A, Rund D. Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. Mediterr J Hematol Infect Dis. 2009;1(1):e2009028.PubMedPubMedCentral Ricerca BM, Di Girolamo A, Rund D. Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. Mediterr J Hematol Infect Dis. 2009;1(1):e2009028.PubMedPubMedCentral
6.
go back to reference Enli Y, Balci YI, Gönen C, et al. Adipocytokine concentrations in children with different types of beta-thalassemia. Scand J Clin Lab Invest. 2014;74(4):306–11.CrossRefPubMed Enli Y, Balci YI, Gönen C, et al. Adipocytokine concentrations in children with different types of beta-thalassemia. Scand J Clin Lab Invest. 2014;74(4):306–11.CrossRefPubMed
7.
go back to reference Chaliasos N, Challa A, Hatzimichael E, et al. Serum adipocytokine and vascular inflammation marker levels in beta-thalassaemia major patients. Acta Haematol. 2010;124:191–6.CrossRefPubMed Chaliasos N, Challa A, Hatzimichael E, et al. Serum adipocytokine and vascular inflammation marker levels in beta-thalassaemia major patients. Acta Haematol. 2010;124:191–6.CrossRefPubMed
8.
go back to reference Kanavaki I, Makrythanasis P, Lazaropoulou C, et al. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia. Blood Cells Mol Dis. 2009;43(3):230–4.CrossRefPubMed Kanavaki I, Makrythanasis P, Lazaropoulou C, et al. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia. Blood Cells Mol Dis. 2009;43(3):230–4.CrossRefPubMed
9.
go back to reference Paz-Filho GJ, Delibasi T, Erol HK, et al. Cellular immunity before and after leptin replacement therapy. J Pediatr Endocrinol Metab. 2009;22(11):1069–74.CrossRefPubMed Paz-Filho GJ, Delibasi T, Erol HK, et al. Cellular immunity before and after leptin replacement therapy. J Pediatr Endocrinol Metab. 2009;22(11):1069–74.CrossRefPubMed
10.
go back to reference Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med. 2012;33:35–45.CrossRefPubMed Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med. 2012;33:35–45.CrossRefPubMed
11.
go back to reference Sun Y, Xun K, Wang C, et al. Adiponectin, an unlocking adipocytokine. Cardiovasc Ther. 2009;27:59–75.CrossRefPubMed Sun Y, Xun K, Wang C, et al. Adiponectin, an unlocking adipocytokine. Cardiovasc Ther. 2009;27:59–75.CrossRefPubMed
12.
go back to reference Makis A, Challa A, Hatzimichael E, et al. Adipocytokines are related to haemolytic and inflammatory biomarkers in sickle cell beta thalassaemia. Br J Haematol. 2013;163(1):142–4.CrossRefPubMed Makis A, Challa A, Hatzimichael E, et al. Adipocytokines are related to haemolytic and inflammatory biomarkers in sickle cell beta thalassaemia. Br J Haematol. 2013;163(1):142–4.CrossRefPubMed
13.
go back to reference Shahramian I, Akhlaghi E, Ramezani A, et al. A study of leptin serum concentrations in patients with major beta-thalassemia. Iran J Ped Hematol Oncol. 2013;3(2):59–63.PubMedPubMedCentral Shahramian I, Akhlaghi E, Ramezani A, et al. A study of leptin serum concentrations in patients with major beta-thalassemia. Iran J Ped Hematol Oncol. 2013;3(2):59–63.PubMedPubMedCentral
14.
go back to reference Moshtaghi-Kashanian GR, Razavi F. Ghrelin and leptin levels in relation to puberty and reproductive function in patients with beta-thalassemia. Hormones. 2009;8(3):207–13.CrossRefPubMed Moshtaghi-Kashanian GR, Razavi F. Ghrelin and leptin levels in relation to puberty and reproductive function in patients with beta-thalassemia. Hormones. 2009;8(3):207–13.CrossRefPubMed
15.
go back to reference Choobineh H, Dehghani SJ, Alizadeh SH, et al. Evaluation of leptin levels in major beta thalassemic patients. Int J Hematol Oncol Stem Cell Res. 2010;3(4):1–4. Choobineh H, Dehghani SJ, Alizadeh SH, et al. Evaluation of leptin levels in major beta thalassemic patients. Int J Hematol Oncol Stem Cell Res. 2010;3(4):1–4.
16.
go back to reference Karachaliou F, Vlachopapadopoulou E, Theochari M, et al. Leptin levels in patients with thalassemia major. Minerva Pediatr. 2006;58(4):373–8.PubMed Karachaliou F, Vlachopapadopoulou E, Theochari M, et al. Leptin levels in patients with thalassemia major. Minerva Pediatr. 2006;58(4):373–8.PubMed
17.
go back to reference Al-Awadhi AM, Alfadhli SM, Al-Khaldi D, et al. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients. Int J Lab Hematol. 2010;32(2):191–6.CrossRefPubMed Al-Awadhi AM, Alfadhli SM, Al-Khaldi D, et al. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients. Int J Lab Hematol. 2010;32(2):191–6.CrossRefPubMed
18.
go back to reference Grady RW, Akbar AN, Giardina PJ, et al. Disproportionate lymphoid cell subsets in thalassemia major: the relative contributions of transfusion and splenectomy. Br J Haematol. 1985;59:713–21.CrossRefPubMed Grady RW, Akbar AN, Giardina PJ, et al. Disproportionate lymphoid cell subsets in thalassemia major: the relative contributions of transfusion and splenectomy. Br J Haematol. 1985;59:713–21.CrossRefPubMed
19.
go back to reference Dwyer J, Wood C, McNamara J, et al. Abnormalities in the immune system of children with beta-thalassemia major. Clin Exp Immunol. 1987;68:621–9.PubMedPubMedCentral Dwyer J, Wood C, McNamara J, et al. Abnormalities in the immune system of children with beta-thalassemia major. Clin Exp Immunol. 1987;68:621–9.PubMedPubMedCentral
20.
go back to reference Pattanapanyasat K, Thepthai C, Lamchiagdhase P, et al. Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry. 2000;42(1):11–7.CrossRefPubMed Pattanapanyasat K, Thepthai C, Lamchiagdhase P, et al. Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry. 2000;42(1):11–7.CrossRefPubMed
21.
go back to reference Oren H, Sahin B, Irken G, et al. Neutrophil apoptosis in patients with beta-thalassemia major. Pediatr Hematol Oncol. 2003;20(3):237–43.CrossRefPubMed Oren H, Sahin B, Irken G, et al. Neutrophil apoptosis in patients with beta-thalassemia major. Pediatr Hematol Oncol. 2003;20(3):237–43.CrossRefPubMed
22.
go back to reference Khalifa AS, Fattah SA, Maged Z, et al. Immunoglobulin levels, opsonic activity and phagocytic power in Egyptian thalassemic children. Acta Haematol. 1983;69(2):136–9.CrossRefPubMed Khalifa AS, Fattah SA, Maged Z, et al. Immunoglobulin levels, opsonic activity and phagocytic power in Egyptian thalassemic children. Acta Haematol. 1983;69(2):136–9.CrossRefPubMed
24.
25.
go back to reference Walter PB, Porter J, Evans P, et al. Increased leucocyte apoptosis in transfused β-thalassaemia patients. Br J Haematol. 2013;160:399–403.CrossRefPubMed Walter PB, Porter J, Evans P, et al. Increased leucocyte apoptosis in transfused β-thalassaemia patients. Br J Haematol. 2013;160:399–403.CrossRefPubMed
26.
go back to reference Scheel-Toellner D, Wang K, Craddock R, et al. Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood. 2004;104(8):2557–64.CrossRefPubMed Scheel-Toellner D, Wang K, Craddock R, et al. Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood. 2004;104(8):2557–64.CrossRefPubMed
Metadata
Title
Leukocytes apoptosis and adipocytokines in children with beta thalassemia major
Authors
Khalid I. Elsayh
Wafaa S. Mohammed
Asmaa M. Zahran
Khaled Saad
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 3/2016
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-015-0361-6

Other articles of this Issue 3/2016

Clinical and Experimental Medicine 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.